1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Active Tuberculosis Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Active Tuberculosis Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Active Tuberculosis Treatment by Country/Region, 2018, 2022 & 2029
2.2 Active Tuberculosis Treatment Segment by Type
2.2.1 Rifampin
2.2.2 Pyrazinamide
2.2.3 Ethambutol
2.3 Active Tuberculosis Treatment Sales by Type
2.3.1 Global Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Active Tuberculosis Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Active Tuberculosis Treatment Sale Price by Type (2018-2023)
2.4 Active Tuberculosis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores and Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Active Tuberculosis Treatment Sales by Application
2.5.1 Global Active Tuberculosis Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Active Tuberculosis Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Active Tuberculosis Treatment Sale Price by Application (2018-2023)
3 Global Active Tuberculosis Treatment by Company
3.1 Global Active Tuberculosis Treatment Breakdown Data by Company
3.1.1 Global Active Tuberculosis Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Active Tuberculosis Treatment Sales Market Share by Company (2018-2023)
3.2 Global Active Tuberculosis Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Active Tuberculosis Treatment Revenue by Company (2018-2023)
3.2.2 Global Active Tuberculosis Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Active Tuberculosis Treatment Sale Price by Company
3.4 Key Manufacturers Active Tuberculosis Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Tuberculosis Treatment Product Location Distribution
3.4.2 Players Active Tuberculosis Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Active Tuberculosis Treatment by Geographic Region
4.1 World Historic Active Tuberculosis Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Active Tuberculosis Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Active Tuberculosis Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Active Tuberculosis Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Active Tuberculosis Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Active Tuberculosis Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Active Tuberculosis Treatment Sales Growth
4.4 APAC Active Tuberculosis Treatment Sales Growth
4.5 Europe Active Tuberculosis Treatment Sales Growth
4.6 Middle East & Africa Active Tuberculosis Treatment Sales Growth
5 Americas
5.1 Americas Active Tuberculosis Treatment Sales by Country
5.1.1 Americas Active Tuberculosis Treatment Sales by Country (2018-2023)
5.1.2 Americas Active Tuberculosis Treatment Revenue by Country (2018-2023)
5.2 Americas Active Tuberculosis Treatment Sales by Type
5.3 Americas Active Tuberculosis Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Tuberculosis Treatment Sales by Region
6.1.1 APAC Active Tuberculosis Treatment Sales by Region (2018-2023)
6.1.2 APAC Active Tuberculosis Treatment Revenue by Region (2018-2023)
6.2 APAC Active Tuberculosis Treatment Sales by Type
6.3 APAC Active Tuberculosis Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Active Tuberculosis Treatment by Country
7.1.1 Europe Active Tuberculosis Treatment Sales by Country (2018-2023)
7.1.2 Europe Active Tuberculosis Treatment Revenue by Country (2018-2023)
7.2 Europe Active Tuberculosis Treatment Sales by Type
7.3 Europe Active Tuberculosis Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Active Tuberculosis Treatment by Country
8.1.1 Middle East & Africa Active Tuberculosis Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Active Tuberculosis Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Active Tuberculosis Treatment Sales by Type
8.3 Middle East & Africa Active Tuberculosis Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Tuberculosis Treatment
10.3 Manufacturing Process Analysis of Active Tuberculosis Treatment
10.4 Industry Chain Structure of Active Tuberculosis Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Tuberculosis Treatment Distributors
11.3 Active Tuberculosis Treatment Customer
12 World Forecast Review for Active Tuberculosis Treatment by Geographic Region
12.1 Global Active Tuberculosis Treatment Market Size Forecast by Region
12.1.1 Global Active Tuberculosis Treatment Forecast by Region (2024-2029)
12.1.2 Global Active Tuberculosis Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Tuberculosis Treatment Forecast by Type
12.7 Global Active Tuberculosis Treatment Forecast by Application
13 Key Players Analysis
13.1 Lupin
13.1.1 Lupin Company Information
13.1.2 Lupin Active Tuberculosis Treatment Product Portfolios and Specifications
13.1.3 Lupin Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Lupin Main Business Overview
13.1.5 Lupin Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Active Tuberculosis Treatment Product Portfolios and Specifications
13.2.3 Sanofi Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Information
13.3.2 Pfizer Inc. Active Tuberculosis Treatment Product Portfolios and Specifications
13.3.3 Pfizer Inc. Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Inc. Main Business Overview
13.3.5 Pfizer Inc. Latest Developments
13.4 FRESENIUS SE & Co
13.4.1 FRESENIUS SE & Co Company Information
13.4.2 FRESENIUS SE & Co Active Tuberculosis Treatment Product Portfolios and Specifications
13.4.3 FRESENIUS SE & Co Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 FRESENIUS SE & Co Main Business Overview
13.4.5 FRESENIUS SE & Co Latest Developments
13.5 KGaA (Fresenius Kabi)
13.5.1 KGaA (Fresenius Kabi) Company Information
13.5.2 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Product Portfolios and Specifications
13.5.3 KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 KGaA (Fresenius Kabi) Main Business Overview
13.5.5 KGaA (Fresenius Kabi) Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Active Tuberculosis Treatment Product Portfolios and Specifications
13.6.3 Johnson & Johnson Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Active Tuberculosis Treatment Product Portfolios and Specifications
13.7.3 Novartis AG Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 Macleods Pharmaceuticals Ltd.
13.8.1 Macleods Pharmaceuticals Ltd. Company Information
13.8.2 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Macleods Pharmaceuticals Ltd. Main Business Overview
13.8.5 Macleods Pharmaceuticals Ltd. Latest Developments
13.9 ANI Pharmaceuticals, Inc.
13.9.1 ANI Pharmaceuticals, Inc. Company Information
13.9.2 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Product Portfolios and Specifications
13.9.3 ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ANI Pharmaceuticals, Inc. Main Business Overview
13.9.5 ANI Pharmaceuticals, Inc. Latest Developments
13.10 Otsuka Pharmaceutical Co., Ltd.
13.10.1 Otsuka Pharmaceutical Co., Ltd. Company Information
13.10.2 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
13.10.3 Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.11 Teva Pharmaceutical Industries Ltd.
13.11.1 Teva Pharmaceutical Industries Ltd. Company Information
13.11.2 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
13.11.3 Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Active Tuberculosis Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Active Tuberculosis Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rifampin
Table 4. Major Players of Pyrazinamide
Table 5. Major Players of Ethambutol
Table 6. Global Active Tuberculosis Treatment Sales by Type (2018-2023) & (K Units)
Table 7. Global Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
Table 8. Global Active Tuberculosis Treatment Revenue by Type (2018-2023) & ($ million)
Table 9. Global Active Tuberculosis Treatment Revenue Market Share by Type (2018-2023)
Table 10. Global Active Tuberculosis Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Active Tuberculosis Treatment Sales by Application (2018-2023) & (K Units)
Table 12. Global Active Tuberculosis Treatment Sales Market Share by Application (2018-2023)
Table 13. Global Active Tuberculosis Treatment Revenue by Application (2018-2023)
Table 14. Global Active Tuberculosis Treatment Revenue Market Share by Application (2018-2023)
Table 15. Global Active Tuberculosis Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Active Tuberculosis Treatment Sales by Company (2018-2023) & (K Units)
Table 17. Global Active Tuberculosis Treatment Sales Market Share by Company (2018-2023)
Table 18. Global Active Tuberculosis Treatment Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Active Tuberculosis Treatment Revenue Market Share by Company (2018-2023)
Table 20. Global Active Tuberculosis Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Active Tuberculosis Treatment Producing Area Distribution and Sales Area
Table 22. Players Active Tuberculosis Treatment Products Offered
Table 23. Active Tuberculosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Active Tuberculosis Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Active Tuberculosis Treatment Sales Market Share Geographic Region (2018-2023)
Table 28. Global Active Tuberculosis Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Active Tuberculosis Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Active Tuberculosis Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Active Tuberculosis Treatment Sales Market Share by Country/Region (2018-2023)
Table 32. Global Active Tuberculosis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Active Tuberculosis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Active Tuberculosis Treatment Sales by Country (2018-2023) & (K Units)
Table 35. Americas Active Tuberculosis Treatment Sales Market Share by Country (2018-2023)
Table 36. Americas Active Tuberculosis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Active Tuberculosis Treatment Revenue Market Share by Country (2018-2023)
Table 38. Americas Active Tuberculosis Treatment Sales by Type (2018-2023) & (K Units)
Table 39. Americas Active Tuberculosis Treatment Sales by Application (2018-2023) & (K Units)
Table 40. APAC Active Tuberculosis Treatment Sales by Region (2018-2023) & (K Units)
Table 41. APAC Active Tuberculosis Treatment Sales Market Share by Region (2018-2023)
Table 42. APAC Active Tuberculosis Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Active Tuberculosis Treatment Revenue Market Share by Region (2018-2023)
Table 44. APAC Active Tuberculosis Treatment Sales by Type (2018-2023) & (K Units)
Table 45. APAC Active Tuberculosis Treatment Sales by Application (2018-2023) & (K Units)
Table 46. Europe Active Tuberculosis Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Europe Active Tuberculosis Treatment Sales Market Share by Country (2018-2023)
Table 48. Europe Active Tuberculosis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Active Tuberculosis Treatment Revenue Market Share by Country (2018-2023)
Table 50. Europe Active Tuberculosis Treatment Sales by Type (2018-2023) & (K Units)
Table 51. Europe Active Tuberculosis Treatment Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Active Tuberculosis Treatment Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Active Tuberculosis Treatment Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Active Tuberculosis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Active Tuberculosis Treatment Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Active Tuberculosis Treatment Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Active Tuberculosis Treatment Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Active Tuberculosis Treatment
Table 59. Key Market Challenges & Risks of Active Tuberculosis Treatment
Table 60. Key Industry Trends of Active Tuberculosis Treatment
Table 61. Active Tuberculosis Treatment Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Active Tuberculosis Treatment Distributors List
Table 64. Active Tuberculosis Treatment Customer List
Table 65. Global Active Tuberculosis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Active Tuberculosis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Active Tuberculosis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Active Tuberculosis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Active Tuberculosis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Active Tuberculosis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Active Tuberculosis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Active Tuberculosis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Active Tuberculosis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Active Tuberculosis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Active Tuberculosis Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Active Tuberculosis Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Active Tuberculosis Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Active Tuberculosis Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Lupin Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Lupin Active Tuberculosis Treatment Product Portfolios and Specifications
Table 81. Lupin Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Lupin Main Business
Table 83. Lupin Latest Developments
Table 84. Sanofi Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Active Tuberculosis Treatment Product Portfolios and Specifications
Table 86. Sanofi Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Pfizer Inc. Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Inc. Active Tuberculosis Treatment Product Portfolios and Specifications
Table 91. Pfizer Inc. Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Inc. Main Business
Table 93. Pfizer Inc. Latest Developments
Table 94. FRESENIUS SE & Co Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. FRESENIUS SE & Co Active Tuberculosis Treatment Product Portfolios and Specifications
Table 96. FRESENIUS SE & Co Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. FRESENIUS SE & Co Main Business
Table 98. FRESENIUS SE & Co Latest Developments
Table 99. KGaA (Fresenius Kabi) Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Product Portfolios and Specifications
Table 101. KGaA (Fresenius Kabi) Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. KGaA (Fresenius Kabi) Main Business
Table 103. KGaA (Fresenius Kabi) Latest Developments
Table 104. Johnson & Johnson Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson & Johnson Active Tuberculosis Treatment Product Portfolios and Specifications
Table 106. Johnson & Johnson Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Johnson & Johnson Main Business
Table 108. Johnson & Johnson Latest Developments
Table 109. Novartis AG Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis AG Active Tuberculosis Treatment Product Portfolios and Specifications
Table 111. Novartis AG Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Novartis AG Main Business
Table 113. Novartis AG Latest Developments
Table 114. Macleods Pharmaceuticals Ltd. Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
Table 116. Macleods Pharmaceuticals Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Macleods Pharmaceuticals Ltd. Main Business
Table 118. Macleods Pharmaceuticals Ltd. Latest Developments
Table 119. ANI Pharmaceuticals, Inc. Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Product Portfolios and Specifications
Table 121. ANI Pharmaceuticals, Inc. Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. ANI Pharmaceuticals, Inc. Main Business
Table 123. ANI Pharmaceuticals, Inc. Latest Developments
Table 124. Otsuka Pharmaceutical Co., Ltd. Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 125. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
Table 126. Otsuka Pharmaceutical Co., Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 128. Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 129. Teva Pharmaceutical Industries Ltd. Basic Information, Active Tuberculosis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 130. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Product Portfolios and Specifications
Table 131. Teva Pharmaceutical Industries Ltd. Active Tuberculosis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Teva Pharmaceutical Industries Ltd. Main Business
Table 133. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Picture of Active Tuberculosis Treatment
Figure 2. Active Tuberculosis Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Tuberculosis Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Active Tuberculosis Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Active Tuberculosis Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rifampin
Figure 10. Product Picture of Pyrazinamide
Figure 11. Product Picture of Ethambutol
Figure 12. Global Active Tuberculosis Treatment Sales Market Share by Type in 2022
Figure 13. Global Active Tuberculosis Treatment Revenue Market Share by Type (2018-2023)
Figure 14. Active Tuberculosis Treatment Consumed in Hospital Pharmacies
Figure 15. Global Active Tuberculosis Treatment Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 16. Active Tuberculosis Treatment Consumed in Drug Stores and Retail Pharmacies
Figure 17. Global Active Tuberculosis Treatment Market: Drug Stores and Retail Pharmacies (2018-2023) & (K Units)
Figure 18. Active Tuberculosis Treatment Consumed in Online Pharmacies
Figure 19. Global Active Tuberculosis Treatment Market: Online Pharmacies (2018-2023) & (K Units)
Figure 20. Global Active Tuberculosis Treatment Sales Market Share by Application (2022)
Figure 21. Global Active Tuberculosis Treatment Revenue Market Share by Application in 2022
Figure 22. Active Tuberculosis Treatment Sales Market by Company in 2022 (K Units)
Figure 23. Global Active Tuberculosis Treatment Sales Market Share by Company in 2022
Figure 24. Active Tuberculosis Treatment Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Active Tuberculosis Treatment Revenue Market Share by Company in 2022
Figure 26. Global Active Tuberculosis Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Active Tuberculosis Treatment Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Active Tuberculosis Treatment Sales 2018-2023 (K Units)
Figure 29. Americas Active Tuberculosis Treatment Revenue 2018-2023 ($ Millions)
Figure 30. APAC Active Tuberculosis Treatment Sales 2018-2023 (K Units)
Figure 31. APAC Active Tuberculosis Treatment Revenue 2018-2023 ($ Millions)
Figure 32. Europe Active Tuberculosis Treatment Sales 2018-2023 (K Units)
Figure 33. Europe Active Tuberculosis Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Active Tuberculosis Treatment Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Active Tuberculosis Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Americas Active Tuberculosis Treatment Sales Market Share by Country in 2022
Figure 37. Americas Active Tuberculosis Treatment Revenue Market Share by Country in 2022
Figure 38. Americas Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
Figure 39. Americas Active Tuberculosis Treatment Sales Market Share by Application (2018-2023)
Figure 40. United States Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Active Tuberculosis Treatment Sales Market Share by Region in 2022
Figure 45. APAC Active Tuberculosis Treatment Revenue Market Share by Regions in 2022
Figure 46. APAC Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
Figure 47. APAC Active Tuberculosis Treatment Sales Market Share by Application (2018-2023)
Figure 48. China Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Active Tuberculosis Treatment Sales Market Share by Country in 2022
Figure 56. Europe Active Tuberculosis Treatment Revenue Market Share by Country in 2022
Figure 57. Europe Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
Figure 58. Europe Active Tuberculosis Treatment Sales Market Share by Application (2018-2023)
Figure 59. Germany Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Active Tuberculosis Treatment Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Active Tuberculosis Treatment Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Active Tuberculosis Treatment Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Active Tuberculosis Treatment Sales Market Share by Application (2018-2023)
Figure 68. Egypt Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Active Tuberculosis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Active Tuberculosis Treatment in 2022
Figure 74. Manufacturing Process Analysis of Active Tuberculosis Treatment
Figure 75. Industry Chain Structure of Active Tuberculosis Treatment
Figure 76. Channels of Distribution
Figure 77. Global Active Tuberculosis Treatment Sales Market Forecast by Region (2024-2029)
Figure 78. Global Active Tuberculosis Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Active Tuberculosis Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Active Tuberculosis Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Active Tuberculosis Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Active Tuberculosis Treatment Revenue Market Share Forecast by Application (2024-2029)
